US – What we need is… UK – We have this
Posted in News
A fascinating call to arms from Derek Imars (US Pharmacist with a passion for business transformation) picking up on the significant potential for medicines stock disruption following the devastation of the Pfizer aseptic manufacturing site in Carolina
In his article he quotes the AJHP: “Overall, less than 1% of medication inventory was judged to have full digital visibility.”
We, in the UK, have had full visibility for the last 5 years and has certainly given us (and continues to) highly valuable information to mitigate shortages – think Brexit, think Covid, think alteplase shortages. This data also allows hospitals better manage medicines stock inventories and minimize financial losses.
There is plenty in the Rx-info pipeline including bringing Epic and Meditech data into full integration, extending the functionality in Exend+ and reviewing our reporting in Define and Refine. All efforts to stay ahead of the curve (and the US)!